Highlights
The global Point of Care Pregnancy and Fertility Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Point of Care Pregnancy and Fertility Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Point of Care Pregnancy and Fertility Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Point of Care Pregnancy and Fertility Testing in Hypermarkets & supermarkets is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Point of Care Pregnancy and Fertility Testing include Alere, Ani Biotech Oy, Beckman Coulter, bioMerieux, Church & Dwight, EKF, Insight Pharmaceuticals, Meridian and OPKO Health, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point of Care Pregnancy and Fertility Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Pregnancy and Fertility Testing.
The Point of Care Pregnancy and Fertility Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point of Care Pregnancy and Fertility Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Pregnancy and Fertility Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Alere
Ani Biotech Oy
Beckman Coulter
bioMerieux
Church & Dwight
EKF
Insight Pharmaceuticals
Meridian
OPKO Health
Polymed Therapeutics
Polymedco
Quidel
Radiometer
Roche
Siemens Healthcare
Trinity
Segment by Type
Human chorionic Gonadotropin (hcg) urine test
FSH urine test
Human chorionic Gonadotropin (hcg) blood test
Luteinizing hormone (LH) urine test
Segment by Application
Hypermarkets & supermarkets
Gynaecology & fertility clinics
Pharmacy
Online sales
Drugstores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care Pregnancy and Fertility Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Point of Care Pregnancy and Fertility Testing 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Human chorionic Gonadotropin (hcg) urine test
1.2.3 FSH urine test
1.2.4 Human chorionic Gonadotropin (hcg) blood test
1.2.5 Luteinizing hormone (LH) urine test
1.3 麻豆原创 by Application
1.3.1 Global Point of Care Pregnancy and Fertility Testing 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hypermarkets & supermarkets
1.3.3 Gynaecology & fertility clinics
1.3.4 Pharmacy
1.3.5 Online sales
1.3.6 Drugstores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Pregnancy and Fertility Testing 麻豆原创 Perspective (2018-2029)
2.2 Point of Care Pregnancy and Fertility Testing Growth Trends by Region
2.2.1 Global Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point of Care Pregnancy and Fertility Testing Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Point of Care Pregnancy and Fertility Testing Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Point of Care Pregnancy and Fertility Testing 麻豆原创 Dynamics
2.3.1 Point of Care Pregnancy and Fertility Testing Industry Trends
2.3.2 Point of Care Pregnancy and Fertility Testing 麻豆原创 Drivers
2.3.3 Point of Care Pregnancy and Fertility Testing 麻豆原创 Challenges
2.3.4 Point of Care Pregnancy and Fertility Testing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Pregnancy and Fertility Testing Players by Revenue
3.1.1 Global Top Point of Care Pregnancy and Fertility Testing Players by Revenue (2018-2023)
3.1.2 Global Point of Care Pregnancy and Fertility Testing Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Point of Care Pregnancy and Fertility Testing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Pregnancy and Fertility Testing Revenue
3.4 Global Point of Care Pregnancy and Fertility Testing 麻豆原创 Concentration Ratio
3.4.1 Global Point of Care Pregnancy and Fertility Testing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Pregnancy and Fertility Testing Revenue in 2022
3.5 Point of Care Pregnancy and Fertility Testing Key Players Head office and Area Served
3.6 Key Players Point of Care Pregnancy and Fertility Testing Product Solution and Service
3.7 Date of Enter into Point of Care Pregnancy and Fertility Testing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Pregnancy and Fertility Testing Breakdown Data by Type
4.1 Global Point of Care Pregnancy and Fertility Testing Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Point of Care Pregnancy and Fertility Testing Forecasted 麻豆原创 Size by Type (2024-2029)
5 Point of Care Pregnancy and Fertility Testing Breakdown Data by Application
5.1 Global Point of Care Pregnancy and Fertility Testing Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Point of Care Pregnancy and Fertility Testing Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Point of Care Pregnancy and Fertility Testing 麻豆原创 Size (2018-2029)
6.2 North America Point of Care Pregnancy and Fertility Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Country (2018-2023)
6.4 North America Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Pregnancy and Fertility Testing 麻豆原创 Size (2018-2029)
7.2 Europe Point of Care Pregnancy and Fertility Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Country (2018-2023)
7.4 Europe Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Pregnancy and Fertility Testing 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Point of Care Pregnancy and Fertility Testing 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Pregnancy and Fertility Testing 麻豆原创 Size (2018-2029)
9.2 Latin America Point of Care Pregnancy and Fertility Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Pregnancy and Fertility Testing 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Point of Care Pregnancy and Fertility Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care Pregnancy and Fertility Testing 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Detail
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Pregnancy and Fertility Testing Introduction
11.1.4 Alere Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.1.5 Alere Recent Development
11.2 Ani Biotech Oy
11.2.1 Ani Biotech Oy Company Detail
11.2.2 Ani Biotech Oy Business Overview
11.2.3 Ani Biotech Oy Point of Care Pregnancy and Fertility Testing Introduction
11.2.4 Ani Biotech Oy Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.2.5 Ani Biotech Oy Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Detail
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Point of Care Pregnancy and Fertility Testing Introduction
11.3.4 Beckman Coulter Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.3.5 Beckman Coulter Recent Development
11.4 bioMerieux
11.4.1 bioMerieux Company Detail
11.4.2 bioMerieux Business Overview
11.4.3 bioMerieux Point of Care Pregnancy and Fertility Testing Introduction
11.4.4 bioMerieux Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.4.5 bioMerieux Recent Development
11.5 Church & Dwight
11.5.1 Church & Dwight Company Detail
11.5.2 Church & Dwight Business Overview
11.5.3 Church & Dwight Point of Care Pregnancy and Fertility Testing Introduction
11.5.4 Church & Dwight Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.5.5 Church & Dwight Recent Development
11.6 EKF
11.6.1 EKF Company Detail
11.6.2 EKF Business Overview
11.6.3 EKF Point of Care Pregnancy and Fertility Testing Introduction
11.6.4 EKF Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.6.5 EKF Recent Development
11.7 Insight Pharmaceuticals
11.7.1 Insight Pharmaceuticals Company Detail
11.7.2 Insight Pharmaceuticals Business Overview
11.7.3 Insight Pharmaceuticals Point of Care Pregnancy and Fertility Testing Introduction
11.7.4 Insight Pharmaceuticals Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.7.5 Insight Pharmaceuticals Recent Development
11.8 Meridian
11.8.1 Meridian Company Detail
11.8.2 Meridian Business Overview
11.8.3 Meridian Point of Care Pregnancy and Fertility Testing Introduction
11.8.4 Meridian Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.8.5 Meridian Recent Development
11.9 OPKO Health
11.9.1 OPKO Health Company Detail
11.9.2 OPKO Health Business Overview
11.9.3 OPKO Health Point of Care Pregnancy and Fertility Testing Introduction
11.9.4 OPKO Health Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.9.5 OPKO Health Recent Development
11.10 Polymed Therapeutics
11.10.1 Polymed Therapeutics Company Detail
11.10.2 Polymed Therapeutics Business Overview
11.10.3 Polymed Therapeutics Point of Care Pregnancy and Fertility Testing Introduction
11.10.4 Polymed Therapeutics Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.10.5 Polymed Therapeutics Recent Development
11.11 Polymedco
11.11.1 Polymedco Company Detail
11.11.2 Polymedco Business Overview
11.11.3 Polymedco Point of Care Pregnancy and Fertility Testing Introduction
11.11.4 Polymedco Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.11.5 Polymedco Recent Development
11.12 Quidel
11.12.1 Quidel Company Detail
11.12.2 Quidel Business Overview
11.12.3 Quidel Point of Care Pregnancy and Fertility Testing Introduction
11.12.4 Quidel Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.12.5 Quidel Recent Development
11.13 Radiometer
11.13.1 Radiometer Company Detail
11.13.2 Radiometer Business Overview
11.13.3 Radiometer Point of Care Pregnancy and Fertility Testing Introduction
11.13.4 Radiometer Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.13.5 Radiometer Recent Development
11.14 Roche
11.14.1 Roche Company Detail
11.14.2 Roche Business Overview
11.14.3 Roche Point of Care Pregnancy and Fertility Testing Introduction
11.14.4 Roche Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.14.5 Roche Recent Development
11.15 Siemens Healthcare
11.15.1 Siemens Healthcare Company Detail
11.15.2 Siemens Healthcare Business Overview
11.15.3 Siemens Healthcare Point of Care Pregnancy and Fertility Testing Introduction
11.15.4 Siemens Healthcare Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.15.5 Siemens Healthcare Recent Development
11.16 Trinity
11.16.1 Trinity Company Detail
11.16.2 Trinity Business Overview
11.16.3 Trinity Point of Care Pregnancy and Fertility Testing Introduction
11.16.4 Trinity Revenue in Point of Care Pregnancy and Fertility Testing Business (2018-2023)
11.16.5 Trinity Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Alere
Ani Biotech Oy
Beckman Coulter
bioMerieux
Church & Dwight
EKF
Insight Pharmaceuticals
Meridian
OPKO Health
Polymed Therapeutics
Polymedco
Quidel
Radiometer
Roche
Siemens Healthcare
Trinity
听
听
*If Applicable.